カテゴリ： Infiniti Research TechNavio, 世界, 医療/バイオ

世界のがん支持療法市場2023～2027：化学療法誘発性貧血、化学療法誘発性好中球減少症、がん性疼痛、化学療法誘発性悪心・嘔吐、その他

■ 英語タイトル：Global Cancer Supportive Care Market 2023-2027

調査会社Technavio社が発行したリサーチレポート（データ管理コード：IRTNTR41301-23）■ 発行会社/調査会社：Technavio
■ 商品コード：IRTNTR41301-23
■ 発行日：2023年1月20日
■ 調査対象地域：北米、ヨーロッパ、アジア、その他地域
■ 産業分野：医薬品
■ ページ数：175
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥380,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD4,000 ⇒換算￥608,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のがん支持療法市場2023～2027：化学療法誘発性貧血、化学療法誘発性好中球減少症、がん性疼痛、化学療法誘発性悪心・嘔吐、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Technavio社の市場調査レポートによると、世界のがん支持療法市場は2022年から2027年の間に6,563.92百万ドルまで展開し、2022年から2027年の間にCAGR 4.62%拡大する見通しです。当調査レポートでは、がん支持療法の世界市場市場を調査対象とし、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、治療領域別（化学療法誘発性貧血、化学療法誘発性好中球減少症、がん性疼痛、化学療法誘発性悪心・嘔吐、その他）分析、流通チャネル別（病院薬局、ドラックストア・小売薬局、オンラインプロバイダー）分析、顧客状況、地域別（北米、ヨーロッパ、アジア、その他地域、アメリカ、イギリス、ドイツ、中国、カナダ）分析、成長要因・課題・動向、企業状況、企業分析などの項目を掲載しています。なお、当レポートに記載されている企業情報には、Acacia Pharma Group Plc、Amgen Inc.、Baxter International Inc.、Bayer AG、Daiichi Sankyo Co. Ltd.、Eli Lilly and Co.などが含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模・予測
・過去の市場規模
・ファイブフォース分析
・世界のがん支持療法市場規模：治療領域別
- 化学療法誘発性貧血における市場規模
- 化学療法誘発性好中球減少症における市場規模
- がん性疼痛における市場規模
- 化学療法誘発性悪心・嘔吐における市場規模
- その他治療領域における市場規模
・世界のがん支持療法市場規模：流通チャネル別
- 病院薬局チャネルの市場規模
- ドラックストア・小売薬局チャネルの市場規模
- オンラインプロバイダーチャネルの市場規模
・顧客状況
・世界のがん支持療法市場規模：地域別
- 北米のがん支持療法市場
- ヨーロッパのがん支持療法市場
- アジアのがん支持療法市場
- その他地域のがん支持療法市場
- アメリカのがん支持療法市場
- イギリスのがん支持療法市場
- ドイツのがん支持療法市場
- 中国のがん支持療法市場
- カナダのがん支持療法市場
・成長要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主なパラメーターの解析によって得られた、複数の情報源からの情報を、調査・統合・総括することにより、市場の全体像を事細かに提示します。また、主要な業界のインフルエンサーを特定することにより、多様な市場の側面を提供します。これらのデータは包括的​​で信頼性が高く、一次・二次の広範な研究の結果です。Technavio社の市場調査レポートは、確かな市場の成長を推測するための定性的、定量的調査を行い、完全な競争状況、そして詳細なベンダー選択方法と分析を提供します。

世界のがん支持療法市場 2023-2027年

Technavio社は、がん支持療法市場をモニターしており、2022年から2027年にかけて6,563.92百万ドルの成長が予測され、予測期間中のCAGRは4.62%で加速すると予測しています。当レポートでは、がん支持療法市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析も提供しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、がん患者の有病率の増加、がん治療に伴う多くの副作用、発展途上国における未開拓の可能性などが原動力となっています。

Technavioのがん支持療法市場は以下のように区分されます：

・流通チャネル別：
– 病院薬局
– ドラッグストア・小売薬局
– オンラインプロバイダー

・地域別：
– 北米
– ヨーロッパ
– アジア
– その他の地域（ROW）

本調査では、がん関連治療におけるバイオシミラーの登場が、今後数年間のがん支持療法市場の成長を促進する主要な理由の1つであると特定しています。また、バイオシミラーの製造活動のアウトソーシングや様々な戦略の採用は、市場の大きな需要につながるでしょう。

Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。

当レポートでは、がん支持療法市場について以下の分野をカバーしています：
– がん支持療法市場のサイジング
– がん支持療法市場の予測
– がん支持療法市場の産業分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、Acacia Pharma Group Plc, Amgen Inc., Baxter International Inc., Bayer AG, Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Helsinn Healthcare SA, Heron Therapeutics Inc., Johnson and Johnson, Kyowa Kirin Co. Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Purdue Pharma LP, RELIEF THERAPEUTICS Holding SA, Sanofi SA, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltdなどの企業情報が含まれています。また、がん支持療法市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。

Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Therapeutic Area
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global cancer supportive care market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global cancer supportive care market 2017 – 2021 ($ million)
o 4.2 Therapeutic area Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Therapeutic area Segment 2017 – 2021 ($ million)
o 4.3 Distribution channel Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Distribution channel Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Therapeutic Area
o 6.1 Market segments
o Exhibit 30: Chart on Therapeutic Area – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Therapeutic Area – Market share 2022-2027 (%)
o 6.2 Comparison by Therapeutic Area
o Exhibit 32: Chart on Comparison by Therapeutic Area
o Exhibit 33: Data Table on Comparison by Therapeutic Area
o 6.3 Chemotherapy-induced anemia – Market size and forecast 2022-2027
o Exhibit 34: Chart on Chemotherapy-induced anemia – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Chemotherapy-induced anemia – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Chemotherapy-induced anemia – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Chemotherapy-induced anemia – Year-over-year growth 2022-2027 (%)
o 6.4 Chemotherapy-induced neutropenia – Market size and forecast 2022-2027
o Exhibit 38: Chart on Chemotherapy-induced neutropenia – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Chemotherapy-induced neutropenia – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Chemotherapy-induced neutropenia – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Chemotherapy-induced neutropenia – Year-over-year growth 2022-2027 (%)
o 6.5 Cancer pain – Market size and forecast 2022-2027
o Exhibit 42: Chart on Cancer pain – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Cancer pain – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Cancer pain – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Cancer pain – Year-over-year growth 2022-2027 (%)
o 6.6 CINV – Market size and forecast 2022-2027
o Exhibit 46: Chart on CINV – Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on CINV – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on CINV – Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on CINV – Year-over-year growth 2022-2027 (%)
o 6.7 Others – Market size and forecast 2022-2027
o Exhibit 50: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 51: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by Therapeutic Area
o Exhibit 54: Market opportunity by Therapeutic Area ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 55: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 56: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 57: Chart on Comparison by Distribution Channel
o Exhibit 58: Data Table on Comparison by Distribution Channel
o 7.3 Hospitals pharmacies – Market size and forecast 2022-2027
o Exhibit 59: Chart on Hospitals pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on Hospitals pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on Hospitals pharmacies – Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on Hospitals pharmacies – Year-over-year growth 2022-2027 (%)
o 7.4 Drug stores and retail pharmacies – Market size and forecast 2022-2027
o Exhibit 63: Chart on Drug stores and retail pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on Drug stores and retail pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on Drug stores and retail pharmacies – Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on Drug stores and retail pharmacies – Year-over-year growth 2022-2027 (%)
o 7.5 Online providers – Market size and forecast 2022-2027
o Exhibit 67: Chart on Online providers – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Online providers – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Online providers – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Online providers – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Distribution Channel
o Exhibit 71: Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 73: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 75: Chart on Geographic comparison
o Exhibit 76: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 77: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 81: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 85: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 89: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 93: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 UK – Market size and forecast 2022-2027
o Exhibit 97: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 101: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 China – Market size and forecast 2022-2027
o Exhibit 105: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 106: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 107: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 108: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.11 Canada – Market size and forecast 2022-2027
o Exhibit 109: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 110: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 111: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 112: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 113: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 114: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 115: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 116: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 117: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 118: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 119: Matrix on vendor position and classification
o 12.3 Amgen Inc.
o Exhibit 120: Amgen Inc. – Overview
o Exhibit 121: Amgen Inc. – Product / Service
o Exhibit 122: Amgen Inc. – Key offerings
o 12.4 Baxter International Inc.
o Exhibit 123: Baxter International Inc. – Overview
o Exhibit 124: Baxter International Inc. – Business segments
o Exhibit 125: Baxter International Inc. – Key news
o Exhibit 126: Baxter International Inc. – Key offerings
o Exhibit 127: Baxter International Inc. – Segment focus
o 12.5 Bayer AG
o Exhibit 128: Bayer AG – Overview
o Exhibit 129: Bayer AG – Business segments
o Exhibit 130: Bayer AG – Key news
o Exhibit 131: Bayer AG – Key offerings
o Exhibit 132: Bayer AG – Segment focus
o 12.6 Daiichi Sankyo Co. Ltd.
o Exhibit 133: Daiichi Sankyo Co. Ltd. – Overview
o Exhibit 134: Daiichi Sankyo Co. Ltd. – Business segments
o Exhibit 135: Daiichi Sankyo Co. Ltd. – Key news
o Exhibit 136: Daiichi Sankyo Co. Ltd. – Key offerings
o Exhibit 137: Daiichi Sankyo Co. Ltd. – Segment focus
o 12.7 F. Hoffmann La Roche Ltd.
o Exhibit 138: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 139: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 140: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 141: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 142: F. Hoffmann La Roche Ltd. – Segment focus
o 12.8 GlaxoSmithKline Plc
o Exhibit 143: GlaxoSmithKline Plc – Overview
o Exhibit 144: GlaxoSmithKline Plc – Business segments
o Exhibit 145: GlaxoSmithKline Plc – Key offerings
o Exhibit 146: GlaxoSmithKline Plc – Segment focus
o 12.9 Heron Therapeutics Inc.
o Exhibit 147: Heron Therapeutics Inc. – Overview
o Exhibit 148: Heron Therapeutics Inc. – Product / Service
o Exhibit 149: Heron Therapeutics Inc. – Key news
o Exhibit 150: Heron Therapeutics Inc. – Key offerings
o 12.10 Johnson and Johnson
o Exhibit 151: Johnson and Johnson – Overview
o Exhibit 152: Johnson and Johnson – Business segments
o Exhibit 153: Johnson and Johnson – Key news
o Exhibit 154: Johnson and Johnson – Key offerings
o Exhibit 155: Johnson and Johnson – Segment focus
o 12.11 Kyowa Kirin Co. Ltd.
o Exhibit 156: Kyowa Kirin Co. Ltd. – Overview
o Exhibit 157: Kyowa Kirin Co. Ltd. – Product / Service
o Exhibit 158: Kyowa Kirin Co. Ltd. – Key offerings
o 12.12 Merck and Co. Inc.
o Exhibit 159: Merck and Co. Inc. – Overview
o Exhibit 160: Merck and Co. Inc. – Business segments
o Exhibit 161: Merck and Co. Inc. – Key news
o Exhibit 162: Merck and Co. Inc. – Key offerings
o Exhibit 163: Merck and Co. Inc. – Segment focus
o 12.13 Novartis AG
o Exhibit 164: Novartis AG – Overview
o Exhibit 165: Novartis AG – Business segments
o Exhibit 166: Novartis AG – Key offerings
o Exhibit 167: Novartis AG – Segment focus
o 12.14 Purdue Pharma LP
o Exhibit 168: Purdue Pharma LP – Overview
o Exhibit 169: Purdue Pharma LP – Product / Service
o Exhibit 170: Purdue Pharma LP – Key offerings
o 12.15 Sanofi SA
o Exhibit 171: Sanofi SA – Overview
o Exhibit 172: Sanofi SA – Business segments
o Exhibit 173: Sanofi SA – Key news
o Exhibit 174: Sanofi SA – Key offerings
o Exhibit 175: Sanofi SA – Segment focus
o 12.16 Sun Pharmaceutical Industries Ltd.
o Exhibit 176: Sun Pharmaceutical Industries Ltd. – Overview
o Exhibit 177: Sun Pharmaceutical Industries Ltd. – Product / Service
o Exhibit 178: Sun Pharmaceutical Industries Ltd. – Key offerings
o 12.17 Teva Pharmaceutical Industries Ltd.
o Exhibit 179: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 180: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 181: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 182: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 183: Teva Pharmaceutical Industries Ltd. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 184: Inclusions checklist
o Exhibit 185: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 186: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 187: Research methodology
o Exhibit 188: Validation techniques employed for market sizing
o Exhibit 189: Information sources
o 13.5 List of abbreviations
o Exhibit 190: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Therapeutic Area
Exhibits6: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global cancer supportive care market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Therapeutic area Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Distribution channel Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Therapeutic Area – Market share 2022-2027 (%)
Exhibits31: Data Table on Therapeutic Area – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Therapeutic Area
Exhibits33: Data Table on Comparison by Therapeutic Area
Exhibits34: Chart on Chemotherapy-induced anemia – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Chemotherapy-induced anemia – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Chemotherapy-induced anemia – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Chemotherapy-induced anemia – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Chemotherapy-induced neutropenia – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Chemotherapy-induced neutropenia – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Chemotherapy-induced neutropenia – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Chemotherapy-induced neutropenia – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Cancer pain – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Cancer pain – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Cancer pain – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Cancer pain – Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on CINV – Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on CINV – Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on CINV – Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on CINV – Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits51: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits52: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Therapeutic Area ($ million)
Exhibits55: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits56: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits57: Chart on Comparison by Distribution Channel
Exhibits58: Data Table on Comparison by Distribution Channel
Exhibits59: Chart on Hospitals pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Hospitals pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Hospitals pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Hospitals pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on Drug stores and retail pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on Drug stores and retail pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on Drug stores and retail pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on Drug stores and retail pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Online providers – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Online providers – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Online providers – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Online providers – Year-over-year growth 2022-2027 (%)
Exhibits71: Market opportunity by Distribution Channel ($ million)
Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits73: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits75: Chart on Geographic comparison
Exhibits76: Data Table on Geographic comparison
Exhibits77: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits109: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits110: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits111: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits112: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits113: Market opportunity By Geographical Landscape ($ million)
Exhibits114: Impact of drivers and challenges in 2022 and 2027
Exhibits115: Overview on Criticality of inputs and Factors of differentiation
Exhibits116: Overview on factors of disruption
Exhibits117: Impact of key risks on business
Exhibits118: Vendors covered
Exhibits119: Matrix on vendor position and classification
Exhibits120: Amgen Inc. – Overview
Exhibits121: Amgen Inc. – Product / Service
Exhibits122: Amgen Inc. – Key offerings
Exhibits123: Baxter International Inc. – Overview
Exhibits124: Baxter International Inc. – Business segments
Exhibits125: Baxter International Inc. – Key news
Exhibits126: Baxter International Inc. – Key offerings
Exhibits127: Baxter International Inc. – Segment focus
Exhibits128: Bayer AG – Overview
Exhibits129: Bayer AG – Business segments
Exhibits130: Bayer AG – Key news
Exhibits131: Bayer AG – Key offerings
Exhibits132: Bayer AG – Segment focus
Exhibits133: Daiichi Sankyo Co. Ltd. – Overview
Exhibits134: Daiichi Sankyo Co. Ltd. – Business segments
Exhibits135: Daiichi Sankyo Co. Ltd. – Key news
Exhibits136: Daiichi Sankyo Co. Ltd. – Key offerings
Exhibits137: Daiichi Sankyo Co. Ltd. – Segment focus
Exhibits138: F. Hoffmann La Roche Ltd. – Overview
Exhibits139: F. Hoffmann La Roche Ltd. – Business segments
Exhibits140: F. Hoffmann La Roche Ltd. – Key news
Exhibits141: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits142: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits143: GlaxoSmithKline Plc – Overview
Exhibits144: GlaxoSmithKline Plc – Business segments
Exhibits145: GlaxoSmithKline Plc – Key offerings
Exhibits146: GlaxoSmithKline Plc – Segment focus
Exhibits147: Heron Therapeutics Inc. – Overview
Exhibits148: Heron Therapeutics Inc. – Product / Service
Exhibits149: Heron Therapeutics Inc. – Key news
Exhibits150: Heron Therapeutics Inc. – Key offerings
Exhibits151: Johnson and Johnson – Overview
Exhibits152: Johnson and Johnson – Business segments
Exhibits153: Johnson and Johnson – Key news
Exhibits154: Johnson and Johnson – Key offerings
Exhibits155: Johnson and Johnson – Segment focus
Exhibits156: Kyowa Kirin Co. Ltd. – Overview
Exhibits157: Kyowa Kirin Co. Ltd. – Product / Service
Exhibits158: Kyowa Kirin Co. Ltd. – Key offerings
Exhibits159: Merck and Co. Inc. – Overview
Exhibits160: Merck and Co. Inc. – Business segments
Exhibits161: Merck and Co. Inc. – Key news
Exhibits162: Merck and Co. Inc. – Key offerings
Exhibits163: Merck and Co. Inc. – Segment focus
Exhibits164: Novartis AG – Overview
Exhibits165: Novartis AG – Business segments
Exhibits166: Novartis AG – Key offerings
Exhibits167: Novartis AG – Segment focus
Exhibits168: Purdue Pharma LP – Overview
Exhibits169: Purdue Pharma LP – Product / Service
Exhibits170: Purdue Pharma LP – Key offerings
Exhibits171: Sanofi SA – Overview
Exhibits172: Sanofi SA – Business segments
Exhibits173: Sanofi SA – Key news
Exhibits174: Sanofi SA – Key offerings
Exhibits175: Sanofi SA – Segment focus
Exhibits176: Sun Pharmaceutical Industries Ltd. – Overview
Exhibits177: Sun Pharmaceutical Industries Ltd. – Product / Service
Exhibits178: Sun Pharmaceutical Industries Ltd. – Key offerings
Exhibits179: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits180: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits181: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits182: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits183: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits184: Inclusions checklist
Exhibits185: Exclusions checklist
Exhibits186: Currency conversion rates for US$
Exhibits187: Research methodology
Exhibits188: Validation techniques employed for market sizing
Exhibits189: Information sources
Exhibits190: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 化学療法誘発性貧血（CIA）のグローバル市場（2023-2032）：グレード1、グレード2、グレード3＆4
  • 電子顕微鏡のグローバル市場2023-2027：半導体、ライフサイエンス、材料科学、ナノテクノロジー
  • 半導体パッケージング材料のグローバル市場2023-2027：有機基板、リードフレーム、ボンディングワイヤ、セラミックパッケージ、その他
  • 携帯式浄水器の世界市場2023～2027
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(IRTNTR41301-23 )"世界のがん支持療法市場2023～2027：化学療法誘発性貧血、化学療法誘発性好中球減少症、がん性疼痛、化学療法誘発性悪心・嘔吐、その他" (英文：Global Cancer Supportive Care Market 2023-2027)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。